Viewing Study NCT04045795


Ignite Creation Date: 2025-12-24 @ 1:47 PM
Ignite Modification Date: 2026-01-28 @ 11:18 AM
Study NCT ID: NCT04045795
Status: COMPLETED
Last Update Posted: 2025-09-12
First Post: 2019-08-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-CD38 monoclonal antibody View